<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="82385">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02021448</url>
  </required_header>
  <id_info>
    <org_study_id>5059</org_study_id>
    <nct_id>NCT02021448</nct_id>
  </id_info>
  <brief_title>Predictive Factors of Obesity-hypoventilation Syndrome (OHS) Among Obese Subjects- ETUDE COHYPOB -</brief_title>
  <official_title>Predictive Factors of Obesity-hypoventilation Syndrome (OHS) Among Obese Subjects- ETUDE COHYPOB -</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <authority>France: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigate whether the course of an isolated nocturnal alveolar hypoventilation can predict
      the future occurrence of obesity-hypoventilation syndrome (OHS) in obese subjects
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Occurrence of obesity-hypoventilation syndrome</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>partial pressure of carbon dioxide in the arterial blood &gt; 45mmHg</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Obesity-hypoventilation Syndrome</condition>
  <condition>Nocturnal Alveolar Hypoventilation</condition>
  <arm_group>
    <arm_group_label>Obesity: BMI &gt; 30 kg/m2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Annual visits among 3 years. During each visit different testings are performed in order to detect an obesity-hypoventilation syndrome (OHS) Polygraphy/Polysomnography, Blood sampling, EKG, Lung function testing, Arterial blood gases, Thoracic radiography, Six-minute walk test, Respiratory questionnaires</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Annual visits among 3 years. During each visit different testings are performed in order to detect an obesity-hypoventilation syndrome (OHS)</intervention_name>
    <description>Polygraphy/Polysomnography,Blood sampling, EKG,Lung function testing,Arterial blood gases,Thoracic radiography,Six-minute walk test,Respiratory questionnaires</description>
    <arm_group_label>Obesity: BMI &gt; 30 kg/m2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Obese volunteer Subject (BMI&gt; 30 kg/m2)

          -  Adults of either sex

          -  Social security affiliation

          -  Written informed consent

        Exclusion criteria:

          -  Confirmed OHS at baseline defined by a daytime hypercapnia with PaCO2&gt; 45mmHg

          -  Any cause of chronic respiratory failure other than obesity such as COPD, chest
             deformation, phrenic nerve paralysis, pulmonary fibrosis, neuromuscular disease, a
             history of mutilating thoracic surgery ...

          -  Obstructive ventilatory defect with FEV1/ FVC &lt;70% post-bronchodilator

          -  Long term oxygen therapy, noninvasive ventilation, continuous positive airway
             pressure

          -  Any serious illness involving life-threatening within 3 years after inclusion

          -  Drug or alcohol abuse

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>KESSLER Romain, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>KESSLER Romain, MD</last_name>
    <phone>03 69 55 06 45</phone>
    <email>romain.kessler@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <zip>49000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frédéric GAGNADOUX, MD</last_name>
      <phone>02 41 35 36 95</phone>
      <phone_ext>0033</phone_ext>
      <email>frgagnadoux@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>FREDERIC GAGNADOUX, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christophe GUT-GOBERT, MD</last_name>
      <phone>02 98 14 50 13</phone>
      <phone_ext>0033</phone_ext>
      <email>christophe.gut-gobert@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Christophe GUT-GOBERT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Cannes</name>
      <address>
        <city>Cannes</city>
        <zip>06400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christophe PERRIN, MD</last_name>
      <phone>04.93.69.71.10</phone>
      <phone_ext>0033</phone_ext>
      <email>c.perrin@ch-cannes.fr</email>
    </contact>
    <investigator>
      <last_name>Christophe PERRIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Louis PEPIN, MD</last_name>
      <phone>04 76 76 55 16</phone>
      <phone_ext>0033</phone_ext>
      <email>jpepin@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Jeran-Louis PEPIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Reims</name>
      <address>
        <city>Reims</city>
        <zip>51100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gaëtan DESLEE, MD</last_name>
      <phone>03 26 78 76 09</phone>
      <phone_ext>0033</phone_ext>
      <email>gdeslee@chu-reims.fr</email>
    </contact>
    <investigator>
      <last_name>Gaëtan DESLEE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Romain KESSLER, MD</last_name>
      <email>romain.kessler@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Romain KESSLER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 19, 2013</lastchanged_date>
  <firstreceived_date>August 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>OHS</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Obesity Hypoventilation Syndrome</mesh_term>
    <mesh_term>Hypoventilation</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
